OMIC |
Singular Genomics Systems, Inc. |
Sep 16, 2024 |
3 |
$1.81M |
4 |
Sep 18, 2024 |
10%+ Owner |
OMIC |
Singular Genomics Systems, Inc. |
Sep 16, 2024 |
0 |
$0 |
3 |
Sep 18, 2024 |
10%+ Owner |
AUPH |
Aurinia Pharmaceuticals Inc. |
Sep 12, 2024 |
0 |
$0 |
3 |
Sep 23, 2024 |
Director |
RAIN |
Rain Oncology Inc. |
Jan 26, 2024 |
1 |
$0 |
4 |
Feb 2, 2024 |
10%+ Owner |
RAIN |
Rain Oncology Inc. |
Dec 14, 2023 |
3 |
-$209K |
4 |
Dec 18, 2023 |
10%+ Owner |
RAIN |
Rain Oncology Inc. |
Oct 11, 2023 |
5 |
$279K |
4 |
Oct 13, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
Jun 1, 2023 |
1 |
$0 |
4 |
Feb 14, 2024 |
10%+ Owner |
RAIN |
Rain Oncology Inc. |
May 30, 2023 |
9 |
$1.16M |
4 |
Jun 1, 2023 |
10%+ Owner |
RAIN |
Rain Oncology Inc. |
May 30, 2023 |
0 |
$0 |
3 |
Jun 1, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
May 25, 2023 |
1 |
$86K |
4 |
May 30, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
May 11, 2023 |
2 |
$87.6K |
4 |
May 15, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
May 8, 2023 |
3 |
$164K |
4 |
May 10, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
May 3, 2023 |
4 |
$548K |
4 |
May 5, 2023 |
10%+ Owner |
TCRR |
TCR2 THERAPEUTICS INC. |
May 3, 2023 |
0 |
$0 |
3 |
May 5, 2023 |
10%+ Owner |
JNCE |
Jounce Therapeutics, Inc. |
May 3, 2023 |
2 |
$87.6M |
4 |
May 5, 2023 |
Director, 10%+ Owner |
JNCE |
Jounce Therapeutics, Inc. |
Mar 13, 2023 |
2 |
$86K |
4 |
Mar 14, 2023 |
10%+ Owner |
JNCE |
Jounce Therapeutics, Inc. |
Mar 13, 2023 |
0 |
$0 |
3 |
Mar 14, 2023 |
10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
Aug 22, 2022 |
11 |
-$59.9M |
4 |
Aug 24, 2022 |
Director, 10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
Aug 22, 2022 |
2 |
-$59.9M |
4 |
Aug 24, 2022 |
Director, 10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
Jan 12, 2022 |
1 |
$0 |
4 |
Jan 14, 2022 |
Director, 10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
Nov 29, 2021 |
5 |
-$1.73M |
4 |
Dec 1, 2021 |
Director, 10%+ Owner |
APVO |
Aptevo Therapeutics Inc. |
Nov 23, 2021 |
7 |
-$10.4M |
4 |
Nov 26, 2021 |
Exit Filing |
APVO |
Aptevo Therapeutics Inc. |
Nov 18, 2021 |
10 |
-$6.5M |
4 |
Nov 22, 2021 |
10%+ Owner |
ODT |
Odonate Therapeutics, Inc. |
Nov 17, 2021 |
8 |
-$5.73M |
4 |
Nov 19, 2021 |
Chief Executive Officer, Director, 10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
May 27, 2021 |
4 |
$1.1M |
4 |
Jun 1, 2021 |
Director, 10%+ Owner |
LJPC |
LA JOLLA PHARMACEUTICAL CO |
May 24, 2021 |
4 |
$1.58M |
4 |
May 26, 2021 |
Director, 10%+ Owner |